The Covid kids starting school unable to speak
Children with speech problems could not access therapy during Covid – but now some are getting expert help.
Similar Posts
New antibiotic compound very exciting, expert says
A new antibiotic compound could help treat a bacterium the World Health Organization classes as a major threat.
Fauci admits social distancing not based on science, ‘sort of just appeared’
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
If You Can Only Exercise On Weekends, That’s Still Great For Your Health, A Study Suggests
The “weekend warrior” exercise pattern once dismissed by experts as not quite good enough may not be so bad after all. A study in this week’s JAMA Network Open finds that people who walk 8,000 or more steps a day once or twice a week achieve cardiovascular benefits and lower mortality rates that are almost…
Vertex shares pop after nonopioid painkiller posts positive midstage trial results
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Shares of Vertex Pharmaceuticals jumped Wednesday after the company’s painkiller, which is being tested as an alternative to opioids, significantly decreased pain in a midstage trial. Those positive results for diabetes patients suffering…
Long Covid GP consultations ‘cost £23m’
Co-lead author Dr Shamil Haroon, from the university, said: “We might expect that patients who are older or who have long-term health conditions will need additional primary care support, but we have also seen additional costs associated with being white and female.”
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
Artur Widak | Nurphoto | Getty Images Shares of Moderna closed more than 13% higher on Tuesday after Oppenheimer upgraded the stock to “outperform,” saying the Covid vaccine maker could market five products by 2026. The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot. The company’s stock…
